Cargando…

Understanding the Stabilizing Effect of Histidine on mAb Aggregation: A Molecular Dynamics Study

[Image: see text] Histidine, a widely used buffer in monoclonal antibody (mAb) formulations, is known to reduce antibody aggregation. While experimental studies suggest a nonelectrostatic, nonstructural (relating to secondary structure preservation) origin of the phenomenon, the underlying microscop...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saurabh, Suman, Kalonia, Cavan, Li, Zongyi, Hollowell, Peter, Waigh, Thomas, Li, Peixun, Webster, John, Seddon, John M., Lu, Jian R., Bresme, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2022
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449975/ https://www.ncbi.nlm.nih.gov/pubmed/35946408 http://dx.doi.org/10.1021/acs.molpharmaceut.2c00453

Ejemplares similares

Investigating the Orientation of an Interfacially Adsorbed Monoclonal Antibody and Its Fragments Using Neutron Reflection
por: Ruane, Sean, et al.
Publicado: (2023)

Recent Advances in Studying Interfacial Adsorption of Bioengineered Monoclonal Antibodies
por: Hollowell, Peter, et al.
Publicado: (2020)

Stability enhancement in a mAb and Fab coformulation
por: Zhang, Hongyu, et al.
Publicado: (2020)

Direct analysis of mAb aggregates in mammalian cell culture supernatant
por: Paul, Albert J, et al.
Publicado: (2014)

SEPPA-mAb: spatial epitope prediction of protein antigens for mAbs
por: Qiu, Tianyi, et al.
Publicado: (2023)

The impact of forced degradation conditions on mAb dimer formation and subsequent influence on aggregation propensity
por: Knight, Michael J., et al.
Publicado: (2022)

Characterization of mAb aggregates in a mammalian cell culture production process
por: Paul, Albert, et al.
Publicado: (2013)

Competitive Adsorption of a Monoclonal Antibody and Nonionic Surfactant at the PDMS/Water Interface
por: Shen, Kangcheng, et al.
Publicado: (2023)

The effect of mAb and excipient cryoconcentration on long-term frozen storage stability – part 2: Aggregate formation and oxidation
por: Bluemel, Oliver, et al.
Publicado: (2021)

Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

Germinality does not necessarily define mAb expression and thermal stability
por: Schwaigerlehner, Linda, et al.
Publicado: (2019)

A new approach to quantification of mAb aggregates using peptide affinity probes
por: Cheung, Crystal S. F., et al.
Publicado: (2017)

Correction: Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPs
por: Fusco, Marnie L., et al.
Publicado: (2015)

The Different Colors of mAbs in Solution
por: Ambrogelly, Alexandre
Publicado: (2021)

Cellular tools for biosimilar mAb analysis
por: Lindemann, Carsten, et al.
Publicado: (2013)

Evolving trends in mAb production processes
por: Shukla, Abhinav A., et al.
Publicado: (2017)

State of the art in anti-cancer mAbs
por: Chiavenna, S. M., et al.
Publicado: (2017)

Pan-sarbecovirus mAb protects from variants
por: Flemming, Alexandra
Publicado: (2021)

A mAb for the detection of the antiretroviral drug emtricitabine
por: Youngpairoj, Ae S., et al.
Publicado: (2022)

Differential Surface Adsorption Phenomena for Conventional and Novel Surfactants Correlates with Changes in Interfacial mAb Stabilization
por: Kanthe, Ankit D., et al.
Publicado: (2022)

Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan
por: Liu, Yanyan, et al.
Publicado: (2023)

Novel strategy for a high-yielding mAb-producing CHO strain (overexpression of non-coding RNA enhanced proliferation and improved mAb yield)
por: Tabuchi, Hisahiro
Publicado: (2013)

Introduction of germline residues improves the stability of anti-HIV mAb 2G12-IgM
por: Chromikova, Veronika, et al.
Publicado: (2015)

Evaluating the expression profile and stability of different UCOE containing vector combinations in mAb-producing CHO cells
por: Nematpour, Fatemeh, et al.
Publicado: (2017)

Understanding the Role of Histidine in the GHSxG Acyltransferase Active Site Motif: Evidence for Histidine Stabilization of the Malonyl-Enzyme Intermediate
por: Poust, Sean, et al.
Publicado: (2014)

Developmental changes in heparan sulfate expression: in situ detection with mAbs
Publicado: (1992)

Conservancy of mAb Epitopes in Ebolavirus Glycoproteins of Previous and 2014 Outbreaks
por: Ponomarenko, Julia, et al.
Publicado: (2014)

Self-Interaction Chromatography of mAbs: Accurate Measurement of Dead Volumes
por: Hedberg, S. H. M., et al.
Publicado: (2015)

Anti-GD2 mAb and Vorinostat synergize in the treatment of neuroblastoma
por: Kroesen, Michiel, et al.
Publicado: (2016)

The Role of Complement in the Mechanism of Action of Therapeutic Anti-Cancer mAbs
por: Golay, Josée, et al.
Publicado: (2020)

Targeting and Efficacy of Novel mAb806-Antibody-Drug Conjugates in Malignant Mesothelioma
por: Chia, Puey-Ling, et al.
Publicado: (2020)

Endoplasmic reticulum retention motif fused to recombinant anti-cancer monoclonal antibody (mAb) CO17-1A affects mAb expression and plant stress response
por: Song, Ilchan, et al.
Publicado: (2018)

A computational method for predicting the aggregation propensity of IgG1 and IgG4(P) mAbs in common storage buffers
por: Heads, James T., et al.
Publicado: (2022)

Strategies for adaptation of mAb-producing CHO cells to serum-free medium
por: Costa, A Rita, et al.
Publicado: (2011)

Successful radioimmunotherapy of established syngeneic rat colon carcinoma with (211)At-mAb
por: Eriksson, Sophie E, et al.
Publicado: (2013)

Characterization of Two Novel mAbs Recognizing Different Epitopes on CD43
por: Kim, Soseul, et al.
Publicado: (2014)

Deamidated gluten: specific detection and characterisation with INRA-DG1 mAb
por: Tranquet, Olivier, et al.
Publicado: (2015)

Glycosylation characterization of therapeutic mAbs by top- and middle-down mass spectrometry
por: Tran, Bao Quoc, et al.
Publicado: (2015)

Plant Recycling for Molecular Biofarming to Produce Recombinant Anti-Cancer mAb
por: Kim, Deuk-Su, et al.
Publicado: (2016)

Tanezumab: a selective humanized mAb for chronic lower back pain
por: Webb, Michael P, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_0nqn4u2beruf0od3d1tqo0om9j